Fig. 3From: Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancerKaplan–Meier survival curves basing on NE biomarker expression and pathological subtype. a OS analyses between adeno-NEPC samples positive for only SYN and those positive for more than one NE biomarker. b OS analyses between adeno-NEPC and adeno-PCa. c Time to CRPC analyses between adeno-NEPC and adeno-PCa. d Time to BCR analyses between adeno-NEPC and adeno-PCa. PCa, prostate cancer; NEPC, neuroendocrine prostate cancer; SYN, synaptophysin; CRPC, castration-resistant prostate cancer; BCR, biochemical recurrenceBack to article page